Phase 3b Trial of NCX 470 in Glaucoma
Latest Information Update: 16 Oct 2024
At a glance
- Drugs NCX 470 (Primary)
- Indications Glaucoma
- Focus Therapeutic Use
- Acronyms Whistler
- 16 Oct 2024 New trial record
- 14 Oct 2024 According to a Nicox media release, company announces results are currently expected in Q1 2025.